Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Stryker Corporation (SYK : NYSE)
 
 • Company Description   
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.

Number of Employees: 46,000

 
 • Price / Volume Information   
Yesterday's Closing Price: $232.25 Daily Weekly Monthly
20 Day Moving Average: 1,691,269 shares
Shares Outstanding: 378.15 (millions)
Market Capitalization: $87,826.27 (millions)
Beta: 0.99
52 Week High: $281.16
52 Week Low: $224.02
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -13.99% -3.14%
12 Week -9.88% -0.93%
Year To Date -13.15% 5.32%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2825 AIRVIEW BLVD
-
KALAMAZOO,MI 49002
USA
ph: 269-385-2600
fax: 269-385-1062
preston.wells@stryker.com http://www.strykercorp.com
 
 • General Corporate Information   
Officers
Kevin A. Lobo - Chairman and Chief Executive Officer and President
Glenn S. Boehnlein - Vice President; Chief Financial Officer
Allan C. Golston - Director
Mary K. Brainerd - Director
Giovanni Caforio - Director

Peer Information
Stryker Corporation (BJCT)
Stryker Corporation (CADMQ)
Stryker Corporation (APNO)
Stryker Corporation (UPDC)
Stryker Corporation (IMTIQ)
Stryker Corporation (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 863667101
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 07/26/22
Share - Related Items
Shares Outstanding: 378.15
Most Recent Split Date: 5.00 (2.00:1)
Beta: 0.99
Market Capitalization: $87,826.27 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 1.20%
Current Fiscal Quarter EPS Consensus Estimate: $2.29 Indicated Annual Dividend: $2.78
Current Fiscal Year EPS Consensus Estimate: $9.64 Payout Ratio: 0.30
Number of Estimates in the Fiscal Year Consensus: 12.00 Change In Payout Ratio: 0.01
Estmated Long-Term EPS Growth Rate: 9.15% Last Dividend Paid: 03/30/2022 - $0.69
Next EPS Report Date: 07/26/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 24.09
Trailing 12 Months: 25.44
PEG Ratio: 2.63
Price Ratios
Price/Book: 5.84
Price/Cash Flow: 19.64
Price / Sales: 5.04
EPS Growth
vs. Year Ago Period: 2.07%
vs. Previous Quarter: -27.31%
Sales Growth
vs. Year Ago Period: 8.15%
vs. Previous Quarter: -9.06%
ROE
03/31/22 - 24.09
12/31/21 - 24.65
09/30/21 - 25.73
ROA
03/31/22 - 10.07
12/31/21 - 10.22
09/30/21 - 10.35
Current Ratio
03/31/22 - 1.98
12/31/21 - 2.20
09/30/21 - 2.13
Quick Ratio
03/31/22 - 1.18
12/31/21 - 1.47
09/30/21 - 1.35
Operating Margin
03/31/22 - 20.02
12/31/21 - 20.31
09/30/21 - 21.06
Net Margin
03/31/22 - 11.56
12/31/21 - 11.65
09/30/21 - 11.40
Pre-Tax Margin
03/31/22 - 13.20
12/31/21 - 13.33
09/30/21 - 13.17
Book Value
03/31/22 - 39.79
12/31/21 - 39.42
09/30/21 - 37.60
Inventory Turnover
03/31/22 - 1.82
12/31/21 - 1.80
09/30/21 - 1.74
Debt-to-Equity
03/31/22 - 0.92
12/31/21 - 0.84
09/30/21 - 0.89
Debt-to-Capital
03/31/22 - 47.99
12/31/21 - 45.60
09/30/21 - 47.11
 

Powered by Zacks Investment Research ©